{"schema_version":"secwatch.filing_event.v1","accession":"0000019584-26-000002","form_type":"8-K","ticker":"CHE","cik":"0000019584","company_name":"CHEMED CORP","filed_at":"2026-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.878173+00:00","generated_at":"2026-05-16T00:29:18.611438+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Chemed Q4 2025 GAAP EPS down 9%, Roto-Rooter segment weak; guidance for 2026 growth","bullets":["Revenue $639.3M flat YoY; GAAP diluted EPS $5.48 (-9%), adjusted EPS $6.42 (-6%).","VITAS revenue +1.9% to $418.8M, ADC +1.3% to 22,462, admissions +6%.","Roto-Rooter revenue -3.7% to $220.6M; adjusted EBITDA -21.1%, margin -477bps to 21.5%.","Repurchased 400,000 shares for $174.6M at avg $436.39; $127.3M remaining authorization.","FY2026 adjusted EPS guidance $23.25-$24.25 vs FY2025 $21.55; weighted to H2."],"urls":{"canonical":"https://secwatch.observer/filing/0000019584-26-000002","json":"https://secwatch.observer/filing/0000019584-26-000002.json","markdown":"https://secwatch.observer/filing/0000019584-26-000002.md","text":"https://secwatch.observer/filing/0000019584-26-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/19584/000001958426000002/0000019584-26-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/19584/000001958426000002/che-20260225x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:29:18.611438+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}